scholarly article | Q13442814 |
P2093 | author name string | Jian Huang | |
Bo Liu | |||
Lan Zhang | |||
Jin Zhang | |||
Yonghui Zhang | |||
Shouyue Zhang | |||
Liang Ouyang | |||
Leilei Fu | |||
Xupeng Tong | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions | Q24548456 | ||
The IntAct molecular interaction database in 2012 | Q24621004 | ||
The Pfam protein families database | Q24650035 | ||
Cancer systems biology: a network modeling perspective | Q24650086 | ||
The Biomolecular Interaction Network Database and related tools 2005 update | Q24794410 | ||
Human protein reference database--2006 update | Q25256955 | ||
Network biology: understanding the cell's functional organization | Q27861027 | ||
How many drug targets are there? | Q28276660 | ||
BioGRID REST Service, BiogridPlugin2 and BioGRID WebGraph: new tools for access to interaction data at BioGRID | Q28304913 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
ON/OFF and beyond--a boolean model of apoptosis | Q28472140 | ||
Mathematical modelling of cell-fate decision in response to death receptor engagement | Q28473094 | ||
Bistability in apoptosis by receptor clustering | Q28475785 | ||
Molecular Dynamics Simulation of Tryptophan Hydroxylase-1: Binding Modes and Free Energy Analysis to Phenylalanine Derivative Inhibitors | Q28681678 | ||
A Bayesian Networks Approach for Predicting Protein-Protein Interactions from Genomic Data | Q29395063 | ||
Assessing the accuracy of prediction algorithms for classification: an overview | Q29615358 | ||
A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data | Q33205902 | ||
HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms | Q33229367 | ||
Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets | Q33347888 | ||
Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells. | Q33589345 | ||
Diverse and specific gene expression responses to stresses in cultured human cells | Q33693122 | ||
Targeting the cancer kinome through polypharmacology | Q33893019 | ||
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. | Q34260622 | ||
Modelling the molecular circuitry of cancer | Q34665971 | ||
Promoting apoptosis as a strategy for cancer drug discovery | Q36292878 | ||
A map of human cancer signaling | Q36327214 | ||
Apoptosis and cancer: the genesis of a research field | Q37529250 | ||
Mitochondrial control of caspase-dependent and -independent cell death | Q37691346 | ||
Systems biology analysis of programmed cell death | Q37764129 | ||
Systems biology of apoptosis signaling networks | Q37776839 | ||
Protein kinase signaling networks in cancer | Q37814680 | ||
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. | Q37826384 | ||
Differential network biology | Q37976573 | ||
Caspase‐mediated programmed cell death pathways as potential therapeutic targets in cancer | Q37994921 | ||
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells | Q40150581 | ||
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis | Q40516096 | ||
Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein | Q41834899 | ||
The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML. | Q46544703 | ||
Prediction of caspase cleavage sites using Bayesian bio-basis function neural networks | Q48501557 | ||
Integrative mathematical oncology | Q51893016 | ||
A mathematical model of caspase function in apoptosis | Q52076640 | ||
Targeting apoptosis pathways in cancer therapy | Q81742188 | ||
Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2'-(aminoaryl)benzothiazoles as Aurora-A inhibitors | Q83548607 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
systems biology | Q815297 | ||
P304 | page(s) | 8071-8088 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer | |
P478 | volume | 6 |
Q55024007 | 3′-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells. |
Q33685138 | Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer |
Q33693093 | Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo |
Q38685579 | Disease gene classification with metagraph representations |
Q42022268 | Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers |
Q36667130 | Identification of Novel Pathways in Plant Lectin-Induced Cancer Cell Apoptosis |
Q37437344 | Identification of polycystic ovary syndrome potential drug targets based on pathobiological similarity in the protein-protein interaction network |
Q36344350 | Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer |
Q39042339 | Natural products as modulator of autophagy with potential clinical prospects |
Q26778962 | Non-muscle myosin II in disease: mechanisms and therapeutic opportunities |
Q28828510 | Penicimenolides A-F, Resorcylic Acid Lactones from Penicillium sp., isolated from the Rhizosphere Soil of Panax notoginseng |
Q37376352 | Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling |
Q38448169 | Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer |
Q90577128 | Systems biology approaches based discovery of a small molecule inhibitor targeting both c-Met/PARP-1 and inducing cell death in breast cancer |
Q35753307 | Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer |
Q38881119 | Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy |
Search more.